Ocugen, Inc. — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Shankar Musunuri (CEO) and Treerita Johnson-Greene (CFO) signed standard Sarbanes-Oxley certifications on August 6, 2026 for the Q2 2026 10-Q (quarter ended June 30, 2026). The certifications affirm that the financial statements fairly present the company's financial condition and results of operations, and that disclosure controls and internal controls over financial reporting are effective. No material weaknesses, deficiencies, or fraud are mentioned.
Why this rating
Routine SOX certification with no disclosed control failures or restatement risk; standard quarterly filing requirement.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.